Investor Redressal

Investors are requested to address their queries/complaints/grievances, if any, to the following:

    • The Company Secretary & Compliance Officer
      Norris Medicines Limited
      901/3, 4, 5, 801/P & 802, GIDC Industrial Estate,
      Ankleshwar-393 002 (Gujarat).
      Phone : 02646 – 223462, 227530
      Fax No : 02646 – 250126
      E-mail : liaison@norrismedicines.com
      CIN : L24230MH1990PLC058071

 

    • Registrar & Transfer Agents:
      Purva Sharegistry (India) Pvt. Ltd.
      9, Shiv Shakti Ind. Estt.
      J. R. Boricha Marg, Off. N. M. Joshi Marg,
      Near Lodha Excelus, Lower Parel (East),
      Mumbai – 400011.
      Phone : 2301 8261 / 2301 6761
      Fax No : 2301 2517
      E-mail : busicomp@vsnl.com

 

    • Listing Details
      BSE Ltd – 524414
      Demat ISIN Number in NSDL
      & CDSL for Equity Shares : INE744C01029

 

    • Contact Details of Key Managerial Personnel (KMP’s) authorized for the purpose of determining materiality
Name & Designation of KMP Contact Details Email
Mr. Vimal Shah, Managing Director 02646-223462, Ext. 202 norrismedicines@gmail.com
Mr. Iqubal Patel, Chief Financial Officer 02646 – 223462, 227530 accounts@norrismedicines.com
Mr. Pratik Christian, Company Secretary 02646 – 223462, Ext. 208 contact@norrismedicines.com